TRIM47 and triple-negative breast carcinoma: Interestingly, western blotting and published profiles analyses revealed that TRIM47 was significantly overexpressed in triple-negative breast cancer tissues and in triple-negative breast cancer cell lines at protein levels, compared with the non-triple-negative breast cancer cells and non-triple-negative breast cancer specimens, both in protein and mRNA levels (Fig. 1C–E, Supplemental Fig. 7), suggesting that TRIM47 is upregulated and correlates with poor prognosis in triple-negative breast cancer.